Showing results (51-60 of 117) with videos related to

Sort By:
Pageof 12
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 2, 2006
Characterization of cord blood natural killer and lymphokine activated killer lymphocytes following ex vivo cellular engineeringJanet Ayello, Carmella van de Ven, Weiwei Fortino, et al.
Pediatric Transplantation|September 3, 2015
Human herpesvirus-6 viremia is not associated with poor clinical outcomes in children following allogeneic hematopoietic cell transplantationLeah Violago, Zhezhen Jin, Monica Bhatia, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 3, 2016
Risk Factors and Utility of a Risk-Based Algorithm for Monitoring Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections in Pediatric Recipients after Allogeneic Hematopoietic Cell TransplantationEvelyn Rustia, Leah Violago, Zhezhen Jin, et al.
British Journal of Haematology|July 31, 2007
Immunophenotypic identification of possible therapeutic targets in paediatric non-Hodgkin lymphomas: a children's oncology group reportRodney R Miles, Mitchell S Cairo, Prakash Satwani, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 21, 2017
A Multicenter Study of Bacterial Blood Stream Infections in Pediatric Allogeneic Hematopoietic Cell Transplantation Recipients: The Role of Acute Gastrointestinal Graft-versus-Host DiseasePrakash Satwani, Jason L Freedman, Sonali Chaudhury, et al.
Pediatric Blood & Cancer|December 27, 2022
v-SYMPHONY career development series: A collaboration to enhance professional awareness for pediatric hematology oncology traineesAdit L Tal, Kayleen A Bailey, Alexander Chou, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 26, 2016
Survival Impact of Early Post-Transplant Toxicities in Pediatric and Adolescent Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Malignant and Nonmalignant Diseases: Recognizing Risks and Optimizing OutcomesNaima Al Mulla, Justine M Kahn, Zhezhen Jin, et al.
Pediatric Transplantation|August 29, 2017
Safety of hematopoietic cell infusion in children with malignant and non-malignant diseasesChelsea Heneghan, Elana Smilow, Yvette Tanhehco, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 5, 2020
A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host DiseaseJoanne Kurtzberg, Hisham Abdel-Azim, Paul Carpenter, et al.
British Journal of Haematology|October 20, 2011
Adenovirus infection in paediatric allogeneic stem cell transplantation recipients is a major independent factor for significantly increasing the risk of treatment related mortalityDiane George, Nader Kim El-Mallawany, Zhezhen Jin, et al.
Pageof 12